NDC 50242-918 – Tecentriq
Atezolizumab 840 mg/14mL · Injection, Solution · Intravenous
Product NDC50242-918
Product details
- Brand name
- Tecentriq
- Generic name
- Atezolizumab
- Labeler
- Genentech, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761034
- Marketed since
- March 8, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Programmed Death Receptor-1 Blocking Antibody
Active ingredients
- Atezolizumab 840 mg/14mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50242-918-01 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-918-01) / 14 mL in 1 VIAL, SINGLE-USE | Mar 8, 2019 |
Other Tecentriq products
- 50242-917 Atezolizumab 1200 mg/20mL · Injection, Solution · Genentech, Inc.